Patents by Inventor Mumtaz Yaseen

Mumtaz Yaseen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR IMPROVING IMMUNE SYSTEM FUNCTION
    Publication number: 20240093200
    Abstract: Provided herein are compositions and methods for improving immune system function. In particular, provided herein are compositions, methods, and uses of YY1 and EZH2 inhibitors for preventing and reversing T-cell exhaustion (e.g., for use in immunotherapy).
    Type: Application
    Filed: February 21, 2023
    Publication date: March 21, 2024
    Inventors: Richard P. JUNGHANS, Mumtaz YASEEN
  • Compositions and methods for improving immune system function
    Patent number: 11624068
    Abstract: Provided herein are compositions and methods for improving immune system function. In particular, provided herein are compositions, methods, and uses of YY1 and EZH2 inhibitors for preventing and reversing T-cell exhaustion (e.g., for use in immunotherapy).
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: April 11, 2023
    Assignee: Tufts Medical Center, Inc.
    Inventors: Richard P. Junghans, Mumtaz Yaseen
  • Compositions and methods for improving immune system function
    Patent number: 11584934
    Abstract: Provided herein are compositions and methods for improving immune system function. In particular, provided herein are compositions, methods, and uses of YY1 and EZH2 inhibitors for preventing and reversing T-cell exhaustion (e.g., for use in immunotherapy).
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: February 21, 2023
    Assignee: Tufts Medical Center, Inc.
    Inventors: Richard P. Junghans, Mumtaz Yaseen
  • COMPOSITIONS AND METHODS FOR IMPROVING IMMUNE SYSTEM FUNCTION
    Publication number: 20190309301
    Abstract: Provided herein are compositions and methods for improving immune system function. In particular, provided herein are compositions, methods, and uses of YY1 and EZH2 inhibitors for preventing and reversing T-cell exhaustion (e.g., for use in immunotherapy).
    Type: Application
    Filed: July 14, 2017
    Publication date: October 10, 2019
    Inventors: Richard P. Junghans, Mumtaz Yaseen